These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4394057)

  • 1. New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.
    Boissier JR; Ratouis R; Dumont C; Derible PH; Lavaux JP
    J Med Chem; 1970 Sep; 13(5):971-3. PubMed ID: 4394057
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
    Singh N; Srivastava RK; Kulshrestha VK; Sinha JN; Kohli RP; Bhargava KP
    Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity relationship of the beta adrenoreceptor blocking agents.
    Laddu AR; Somani P
    Eur J Pharmacol; 1969 Nov; 8(2):167-70. PubMed ID: 4391503
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
    Okuda K; Chiba S; Taira N; Hashimoto K
    Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

  • 10. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 11. Pressor effect of beta blocking agents in rats.
    Regoli D; Regoli U; Gysling E
    Can J Physiol Pharmacol; 1972 Mar; 50(3):207-14. PubMed ID: 4402339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Imamura H; Nakamura T; Kimura T
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ring substitution in 1-isopropylamino-3-phenoxypropan-2-ol on beta-adrenoceptor inhibition.
    Barrett AM; Wale JL
    Eur J Pharmacol; 1970; 12(3):372-4. PubMed ID: 4395558
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
    Stanton HC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog.
    Giles RE; Finkel MP
    Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on cardiovascular drugs. 5. 1-Amino-3-phenoxy-2-propanol derivatives as -adrenergic blocking agents.
    Nakanishi M; Muro T; Chihara Y; Imamura H; Nakao T
    J Med Chem; 1972 Jan; 15(1):45-8. PubMed ID: 4399806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.